by Lupus Foundation, Ohio | Mar 12, 2026 | Lupus Foundation of America, News & Events
The Fast Track designation was supported by positive topline results from its Phase 2b JASMINE study.This post was originally published on this...
by Lupus Foundation, Ohio | Mar 11, 2026 | Lupus Foundation of America, News & Events
New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.This post was originally published on this...
by | Mar 6, 2026 | Lupus Foundation of America
This post was originally published on this site
by Lupus Foundation, Ohio | Mar 3, 2026 | Lupus Foundation of America, News & Events
A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis (LN).This post was originally published on this...
by | Mar 1, 2026 | Lupus Foundation of America
This post was originally published on this site